Achaogen inc. – product pipeline review – 2012


Published on announce The Latest report -Achaogen Inc. – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Achaogen inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Achaogen Inc. – Product Pipeline Review – 2012 Market Direct’s pharmaceuticals report, “Achaogen Inc. - Product PipelineReview - 2012” provides data on the Achaogen Inc.’s research and developmentfocus. The report includes information on current developmental pipeline, completewith latest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Achaogen Inc.’s corporate website, SEC filings, investorpresentations and featured press releases, both from Achaogen Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- Achaogen Inc. - Brief Achaogen Inc. overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Achaogen Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 4
  2. 2. List of Figures 4Achaogen Inc. Snapshot 5Achaogen Inc. Overview 5Key Information 5Key Facts 5Achaogen Inc. – Research and Development Overview 6Key Therapeutic Areas 6Achaogen Inc. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10Achaogen Inc. – Pipeline Products Glance 11Achaogen Inc. Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11Phase I Products/Combination Treatment Modalities 12Achaogen Inc. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13Achaogen Inc. – Drug Profiles 14ACHN 975 14Product Description 14Mechanism of Action 14R&D Progress 14Anti-MRSA Beta-Lactam 15Product Description 15Mechanism of Action 15R&D Progress 15Broad-Spectrum FQ 16Product Description 16Mechanism of Action 16R&D Progress 16Expanded-Spectrum Aminoglycosides Development Program 17Product Description 17Mechanism of Action 17R&D Progress 17Plazomicin 18Product Description 18Mechanism of Action 18R&D Progress 18
  3. 3. List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Acacia Pharma Ltd. – Product Pipeline Review – 2012Acceleron Pharma, Inc. – Product Pipeline Review – 2012Access Pharmaceuticals, Inc. – Product Pipeline Review – 2012Achaogen Inc. – Product Pipeline Review – 2012Acorda Therapeutics, Inc. – Product Pipeline Review – 2012Glycotope GmbH – Product Pipeline Review – 2012Aquinox Pharmaceuticals Inc. – Product Pipeline Review – 2012Avaxia Biologics, Inc. – Product Pipeline Review – 2012Bharat Biotech International Limited – Product Pipeline Review – 2012Bio3 Research S.r.l – Product Pipeline Review – 2012Cardax Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cellceutix Pharmaceuticals, Inc. – Product Pipeline Review – 2012
  4. 4. Curacyte AG – Product Pipeline Review – 2012Fresenius Biotech GmbH – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: